Recursion Pharmaceuticals, Inc. (RXRX) NASDAQ
3.59
+0.15(+4.36%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
3.59
+0.15(+4.36%)
Currency In USD
| Market Cap | 1.83B |
| Enterprise Value | 1.16B |
| P/E Ratio | -3.39 |
| PEG Ratio | -0.09 |
| Price/Sales Ratio | 24.22 |
| Price/Book Ratio | 1.85 |
| Enterprise/Revenue | 15.44 |
| Enterprise/EBITDA | -2.1 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -8.44 |
| Operating Margin | -8.83 |
| Return On Assets | -0.42 |
| Return On Equity | -0.54 |
| Revenue | 74.68M |
| Revenue/Share | 0.13 |
| Gross Profit | -46.27M |
| EBITDA | -559.38M |
| Net Income | -644.76M |
| Diluted EPS | -1.44 |
| Total Cash | 654.47M |
| Total Cash/Share | 1.24 |
| Total Debt | 72.38M |
| Total Debt/Equity | 0.07 |
| Current Ratio | 5.47 |
| Book Value Per Share | 1.94 |
| 52-Week Change | -17.85 |
| 52-Week High | 7.18 |
| 52-Week Low | 2.77 |
| Moving Average 50 Days | 3.28 |
| Moving Average 200 Days | 4.27 |
| Average Volume | 13.99M |
| Shares Outstanding | 447.19M |
| % Held by Institutions | 75.12 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |